早产儿与足月儿对流感疫苗的血浆细胞及血清抗体应答
研究纳入11名早产儿(胎龄≤32周、出生体重≤1500克)与11名足月儿,6-17月龄,首次接种流感疫苗,分别于2012-2013和2013-2014流感季接种两剂灭活三价或四价流感疫苗(第0天和第28天),于第0、10、35、56天及9个月采血。早产儿接种后56天和9个月对全部4株疫苗株的血凝抑制抗体滴度至少与足月儿相等;第35天流感特异性抗体分泌细胞ELISPOT应答早产儿高于足月儿(中位100 vs 30/10^6 PBMC,p=0.04);第35天抗体分泌细胞数与第56天血清血凝抑制滴度正相关(ρ=0.50-0.80);5种抗体分泌细胞亚群频率在两组间无统计学差异,且无特定亚群与血清抗体滴度持久性相关。
要点
- 早产儿接种后56天和9个月对全部4株疫苗株的血凝抑制抗体滴度至少与足月儿相等。
- 第35天流感特异性抗体分泌细胞ELISPOT应答早产儿高于足月儿(中位100 vs 30/10^6 PBMC,p=0.04)。
- 第35天抗体分泌细胞数与第56天血凝抑制滴度正相关(ρ=0.50-0.80),但抗体分泌细胞亚群与抗体持久性无关。
核心结论
- 足月儿和早产儿的流感特异性抗体分泌细胞数与抗体峰值滴度相关,但抗体分泌细胞亚群与抗体应答持久性不相关。
研究设计与样本
- 研究纳入11名早产儿(胎龄≤32周、出生体重≤1500克)和11名足月儿,6-17月龄,首次接种流感疫苗。
- 婴儿在2012-2013和2013-2014流感季分别接种两剂灭活三价或四价流感疫苗,于第0天和第28天接种,于第0、10、35、56天及9个月采血。
- 采用血凝抑制试验检测第0、56天和9个月疫苗特异性抗体,酶联免疫斑点法检测第10和35天疫苗特异性抗体分泌细胞数,流式细胞术检测第0、10和35天抗体分泌细胞亚群。
主要发现
- 早产儿接种后56天和9个月对全部4株疫苗株的血凝抑制抗体滴度至少与足月儿相等。
- 第35天流感特异性抗体分泌细胞ELISPOT应答早产儿高于足月儿(中位100 vs 30/10^6 PBMC,p=0.04)。
- 第35天抗体分泌细胞数与第56天血清血凝抑制滴度正相关(ρ=0.50-0.80)。
- 早产儿与足月儿间5种抗体分泌细胞亚群频率无统计学差异,且无特定抗体分泌细胞亚群与血清抗体滴度持久性相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preterm (PT) infants are at greater risk for severe influenza infection and experience decrements in long-term antibody responses to vaccines. This may related to defects in antibody secreting cell (ASC) generation. OBJECTIVE: To investigate the relationships among the frequencies of influenza-specific antibody secreting cells, ASC numbers and subsets, and antibody responses to influenza vaccines (IV) among PT and full-term (FT) infants. DESIGN/METHODS: We enrolled 11 former PT (≤32weeks' gestation, ≤1500 g' birth weight) and 11FT infants, 6-17months of age, receiving their first influenza immunizations. Infants received two doses of inactivated trivalent (T)IV or quadrivalent (Q)IV during the 2012-2013 and 2013-2014 influenza seasons, respectively, at 0 and 28days, and blood was drawn at 0, 10, 35, and 56days and 9months. Vaccine-specific antibody was measured by hemagglutination inhibition (HAI) at 0 and 56days and 9months, vaccine-specific ASC numbers by enzyme linked immunospot (ELISPOT) at 10 and 35days, and ASC subsets by flow cytometry at 0, 10 and 35days. RESULTS: PT infants had post-vaccine HAI titers to all 4 vaccine strains at least equal to FT infants at 56days and 9months after beginning immunization. Influenza-specific ASC ELISPOT responses at 35days were higher among PT than FT infants (median 100 v. 30 per 106 PBMC, p=0.04). ASC numbers at 35days were positively correlated with serum HAI titers at 56days (ρ=0.50-0.80). There were no statistical differences between PT and FT infants in the frequency of five ASC subsets and no specific ASC subset correlated with durability of serum antibody titers. CONCLUSIONS: Influenza-specific ASC numbers in both FT and PT infants correlated with peak antibody titers, but ASC subsets did not correlate with durability of antibody response.
引用
- D'Angio CT, Wyman CP, Misra RS, et al. Plasma cell and serum antibody responses to influenza vaccine in preterm and full-term infants. Vaccine. 2017. PMID: 28807607. doi:10.1016/j.vaccine.2017.07.115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。